Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 07:58 am Sale |
2024-09-30 | 13G | Kronos Bio, Inc. KRON |
Omega Fund V L.P. | 0 0.000% |
-3,838,883 (Position Closed) |
Filing History |
| 2024-07-02 9:01 pm Sale |
2024-06-28 | 13D | Kronos Bio, Inc. KRON |
BISCHOFBERGER NORBERT W | 12,681,108 21.100% |
-1,470,834 (-10.39%) |
Filing History |
| 2024-06-12 7:32 pm Purchase |
2024-06-10 | 13D | Kronos Bio, Inc. KRON |
BISCHOFBERGER NORBERT W | 14,151,942 23.600% |
3,527,205 (+33.20%) |
Filing History |
| 2023-11-27 4:41 pm Purchase |
2023-11-15 | 13D | Kronos Bio, Inc. KRON |
BISCHOFBERGER NORBERT W | 10,624,737 17.400% |
4,689,577 (+79.01%) |
Filing History |
| 2023-07-07 4:35 pm Sale |
2023-06-30 | 13G | Kronos Bio, Inc. KRON |
BLACKROCK INC BLK |
1,397,345 2.400% |
-1,809,540 (-56.43%) |
Filing History |
| 2023-02-13 4:47 pm Purchase |
2022-12-31 | 13G | Kronos Bio, Inc. KRON |
Omega Fund V L.P. | 3,838,883 6.740% |
20,600 (+0.54%) |
Filing History |
| 2023-02-13 3:23 pm Sale |
2023-02-14 | 13G | Kronos Bio, Inc. KRON |
Capital World Investors | 0 0.000% |
-3,151,414 (Position Closed) |
Filing History |
| 2023-02-09 11:25 am Sale |
2022-12-30 | 13G | Kronos Bio, Inc. KRON |
The Vanguard Group | 1,504,922 2.640% |
-1,887,394 (-55.64%) |
Filing History |
| 2023-02-01 4:54 pm Sale |
2022-12-31 | 13G | Kronos Bio, Inc. KRON |
BLACKROCK INC BLK |
3,206,885 5.600% |
-162,791 (-4.83%) |
Filing History |
| 2022-02-17 4:14 pm Purchase |
2021-12-31 | 13G | Kronos Bio, Inc. KRON |
BISCHOFBERGER NORBERT W | 5,935,160 10.500% |
14,356 (+0.24%) |
Filing History |
| 2022-02-17 4:12 pm Purchase |
2021-12-31 | 13G | Kronos Bio, Inc. KRON |
Arie Belldegrun, M.D. | 3,444,889 6.100% |
3,444,889 (New Position) |
Filing History |
| 2022-02-11 2:59 pm Purchase |
2022-02-14 | 13G | Kronos Bio, Inc. KRON |
Capital World Investors | 3,151,414 5.600% |
3,151,414 (New Position) |
Filing History |
| 2022-02-11 12:22 pm Sale |
2022-02-14 | 13G | Kronos Bio, Inc. KRON |
Capital Research Global Investors | 0 0.000% |
-3,541,573 (Position Closed) |
Filing History |
| 2022-02-10 08:22 am Purchase |
2021-12-31 | 13G | Kronos Bio, Inc. KRON |
The Vanguard Group | 3,392,316 6.020% |
3,392,316 (New Position) |
Filing History |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Kronos Bio, Inc. KRON |
BLACKROCK INC BLK |
3,369,676 6.000% |
3,369,676 (New Position) |
Filing History |
| 2021-05-04 4:01 pm Purchase |
2020-12-31 | 13G | Kronos Bio, Inc. KRON |
BISCHOFBERGER NORBERT W | 5,920,804 10.600% |
5,920,804 (New Position) |
Filing History |
| 2021-02-16 3:52 pm Purchase |
2021-02-16 | 13G | Kronos Bio, Inc. KRON |
Capital Research Global Investors | 3,541,573 6.300% |
3,541,573 (New Position) |
Filing History |
| 2021-02-12 1:22 pm Purchase |
2020-12-31 | 13G | Kronos Bio, Inc. KRON |
Omega Fund V L.P. | 3,818,283 6.800% |
3,818,283 (New Position) |
Filing History |